← Back to Search

Behavioural Intervention

ECHO Program for Diabetes and Chronic Conditions (E4DMMC Trial)

N/A
Waitlist Available
Led By Yiliang Zhu, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up per ehr, -12 to 0 months, 1 to 12 months, 13-24 months
Awards & highlights

Summary

This trial is testing a telehealth program called Project ECHO for patients with diabetes and multiple chronic conditions in New Mexico. The program aims to lower blood sugar levels in these patients by training healthcare teams through

Who is the study for?
This trial is for people with diabetes and other chronic conditions in New Mexico. It's designed to help those treated by primary care providers who may need more support managing complex health issues. To join, participants must be receiving treatment at selected NM clinics.
What is being tested?
The study tests the ECHO program, a telehealth intervention that trains healthcare teams through videoconferencing with specialists. The goal is to see if this training can lower blood sugar levels in patients compared to usual care without the ECHO program.
What are the potential side effects?
Since this trial focuses on education and telementoring rather than medication or medical procedures, there are no direct side effects from interventions like drugs or surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~per ehr, -12 to 0 months, 1 to 12 months, 13-24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and per ehr, -12 to 0 months, 1 to 12 months, 13-24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HbA1c level in control
HbA1c trajectory
Secondary study objectives
Cholesterol
Depression care - Large and Small version
Depression care intervention
+18 more
Other study objectives
HbA1c levels
HbA1c levels and disease progression - newly diagnosed DM
HbA1c levels and disease progression - pre-DM
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ECHO InterventionExperimental Treatment1 Intervention
10 FQHCs from the PMS health system will be randomized to the ECHO Intervention Arm. All healthcare team members in the intervention arm will attend ECHO program sessions, and the FQHCs are the primary subjects of the ECHO intervention. However, the investigators examine outcomes at both the level of the healthcare team and at the level of the patients who are empaneled to the healthcare team. Persons with DMMC cared for by the healthcare teams at the FQHC clinics are the patient population for this intervention.
Group II: ComparatorActive Control1 Intervention
10 FQHCs from the PMS health system will be randomized to the comparator arm which is usual care. Persons with DMMC cared for by the healthcare teams at the FQHC clinics are the patient population for this comparator arm.

Find a Location

Who is running the clinical trial?

Patient-Centered Outcomes Research InstituteOTHER
568 Previous Clinical Trials
27,249,389 Total Patients Enrolled
14 Trials studying Chronic Disease
222,460 Patients Enrolled for Chronic Disease
University of New MexicoLead Sponsor
383 Previous Clinical Trials
3,523,174 Total Patients Enrolled
Presbyterian Medical ServicesUNKNOWN
~13 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top